SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Dividend Declaration

4 Nov 2022 08:30

RNS Number : 2142F
British Smaller Companies VCT PLC
04 November 2022
Β 

British Smaller Companies VCT plc ("the Company")

Special Dividend

Β 

The directors of British Smaller Companies VCT plc ("BSC" or the "Company") are pleased to announce the payment of a special dividend, which will be the third interim dividend for the year ending 31 March 2023 of 4.5 pence per ordinary share ("Special Dividend").

Β 

The payment of the Special Dividend follows the successful exits from two separate investments in Springboard and Intelligent Office.

Β 

Springboard is a leading provider of performance insights for the retail industry across Europe and North America. BSC realised its investment in Springboard in September 2022, generating proceeds of Β£8.7 million, representing a capital profit over cost of Β£5.9 million, an uplift of 30.7 per cent or Β£2.0 million on the carrying value at the beginning of the Company's financial year. Including income, the total return from this investment was Β£9.9 million over a nearly eight year holding period, producing an internal rate of return of 23 per cent and a multiple of 4.1x cost. There is the prospect of further consideration in 2023 based on performance targets, however no value has been taken on these payments at this time.

Β 

Intelligent Office is a leading provider of support services to the legal sector, with more than 9,000 employees in over 60 client sites across the UK. BSC realised its investment in Intelligent Office in September 2022, generating proceeds of Β£6.1 million, representing a capital profit over cost of Β£3.2 million, an uplift of 21.1 per cent or Β£1.1 million on the carrying value at the beginning of the year. Including income, the total return from this investment was Β£7.6 million over an eight and a half year holding period, producing an internal rate of return of 14 per cent and a multiple of 2.6x cost.

Β 

The Special Dividend will be paid on 11 January 2023 to those shareholders on the Company's register at the close of business on 18 November 2022. The ex-dividend date will be 17 November 2022. The Special Dividend will reduce the net asset value by 4.5 pence per ordinary share.

Β 

The Company operates a dividend re-investment scheme ("DRIS"). The latest date for receipt of new or updated DRIS elections in respect of the Special Dividend is the close of business on 2 December 2022.

Β 

4 November 2022

Β 

For further information, please contact:

Β 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVBJBPTMTIMMAT
Date   Source Headline
24th Oct 20249:00 amRNSUpdate on Offers
24th Oct 20249:00 amRNSUpdate on Offers
17th Oct 202412:45 pmRNSPublication of a Prospectus
17th Oct 202412:45 pmRNSPublication of a Prospectus
27th Sep 20247:33 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNS1st Quarter Results
10th Sep 20244:30 pmRNSResult of AGM
10th Sep 20242:00 pmRNSUpdate on new combined offer for subscription
20th Aug 20247:00 amRNSStatement re NAV and Proposed Fundraising
20th Aug 20247:00 amRNSStatement re NAV and Proposed Fundraising
26th Jul 202410:42 amRNSPayment of dividend and allotment of shares
25th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 202412:30 pmRNSAnnual Financial Report
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
13th Dec 20234:00 pmRNSOffer Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.